According to Tandem Diabetes Care
's latest financial reports the company has $0.46 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.46 B | -24.15% |
2022-12-31 | $0.61 B | -1.11% |
2021-12-31 | $0.62 B | 28.64% |
2020-12-31 | $0.48 B | 174.82% |
2019-12-31 | $0.17 B | 36.76% |
2018-12-31 | $0.12 B | 809.99% |
2017-12-31 | $14.17 M | -73.52% |
2016-12-31 | $53.53 M | -24.71% |
2015-12-31 | $71.1 M | 5.68% |
2014-12-31 | $67.28 M | -48.04% |
2013-12-31 | $0.12 B | 654.43% |
2012-12-31 | $17.16 M | 98.25% |
2011-12-31 | $8.65 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 4,799.85% | ๐บ๐ธ USA |
Medtronic MDT | $8.32 B | 1,678.33% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | $0.25 B | -45.56% | ๐บ๐ธ USA |
DexCom DXCM | $2.89 B | 519.13% | ๐บ๐ธ USA |
Insulet PODD | $0.70 B | 50.50% | ๐บ๐ธ USA |